...
首页> 外文期刊>Journal of paediatrics and child health >Intrapleural urokinase versus surgical management of childhood empyema
【24h】

Intrapleural urokinase versus surgical management of childhood empyema

机译:胸膜内尿激酶与儿童脓胸的外科治疗

获取原文
获取原文并翻译 | 示例
           

摘要

Aim: Empyema can be managed conservatively with intravenous antibiotics or invasively with a drain inserted under image guidance or via surgical evacuation. Both approaches are successful but comparisons of the method of drainage are few. This study compared clinical outcomes for empyema in previously well children from a single centre over a 12 year period.Methods: A retrospective analysis of cases over 12 years from the Children's Hospital at Westmead in Sydney was undertaken. Ethics committee approval was obtained.Results: Seventy two cases were identified from medical records, 12 cases were excluded and 60 cases remained. The mean age was 4.7 ± 4.3 years and there was a slight male preponderance. Treatment was divided into surgical management with a large bore drain alone [n = 25] and minimally invasive management with the use of a "pigtail catheter" and intrapleural fibrinolytic ["Urkoinase"][n = 35]. At presentation the mean heart rate and respiratory rate were not statistically different. The median (range) number of doses of urokinase was 5.66 doses (1-12). More fluid was drained with the use of urokinase [594 ml (25-4575 ml) vs. 195 ml (10-1426 ml); p = 0.006], but this did not influence the rate of resolution of fever or the length of hospital stay. A pathogen was isolated in 42.9% of the urokinase group and 68% of the surgical group which approached statistical significance [p = 0.054]. Conclusions: Both large bore surgical drains and "pigtail catheter" drains with the instillation of urokinase lead to similarly favourable treatment outcomes. Either treatment could be recommended depending on local expertise and preferences.
机译:目的:脓胸可以通过静脉内抗生素保守治疗,也可以通过在影像引导下或通过手术疏散插入引流来进行侵入性治疗。两种方法都是成功的,但排水方法的比较很少。这项研究比较了过去12年中来自单个中心的先前表现良好的儿童脓胸的临床结局。方法:对悉尼韦斯特米德儿童医院12年以上病例进行回顾性分析。结果:从病历中鉴定出72例,排除了12例,剩余60例。平均年龄为4.7±4.3岁,男性略有优势。治疗方法分为单独使用大口径引流管的外科手术治疗[n = 25]和使用“辫子导管”和胸膜内溶纤溶酶[“ Urkoinase”]的微创治疗[n = 35]。在介绍时,平均心率和呼吸率无统计学差异。尿激酶剂量的中位数(范围)为5.66剂(1-12)。使用尿激酶[594 ml(25-4575 ml)比195 ml(10-1426 ml)排干更多的液体。 p = 0.006],但这不会影响发烧的缓解率或住院时间。在尿激酶组的42.9%和外科手术组的68%中分离出病原体,具有统计学意义[p = 0.054]。结论:大口径外科引流管和“尾纤导管”引流管均注入尿激酶,导致同样良好的治疗效果。根据当地的专业知识和喜好,都可以推荐两种治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号